Searchable abstracts of presentations at key conferences in endocrinology

ea0034p117 | Clinical practice/governance and case reports | SFEBES2014

Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required

Bhatti Rahila , Grimmett Belinda , McCarthy Maeve , Agusttson Tomas , McGowan Barbara , Powrie Jake , Carroll Paul

Background: Testosterone replacement is the mainstay of treatment for male hypogonadism. The most commonly reported adverse event in testosterone trials is polycythaemia. This study assessed the prevalence of polycythaemia in males receiving testosterone replacement and compared prevalence rates between different treatment preparations.Methods: 216 men were included in this retrospective observational study conducted from January 2009 to December 2012. 1...

ea0031p209 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

The endocrine and metabolic characteristics of a large Bardet–Biedl syndrome clinic population

Mujahid Safa , Huda Mohammed , Forsythe Elizabeth , Hazlehurst Jonathan , Tomlinson Jeremy , Beales Philip , Carroll Paul , McGowan Barbara

Background: Bardet Biedl syndrome (BBS) is a rare autosomal recessive disorder caused by ciliary dysfunction. It is characterised by rod cone dystrophy, polydactyly, renal dysfunction, cognitive impairment. Endocrine consequences are thought to include hypogonadism, obesity and polyuria. However little is known about the endocrine and metabolic abnormalities in adult patients.Methods: One hundred and fifty-four patients with BBS were identified through t...

ea0021p286 | Pituitary | SFEBES2009

Oral and transdermal oestrogen treatments have differing effects on GH sensitivity in hypopituitary women receiving GH replacement

Tanna Amit , Madula Rajiv , Sandhu Harinderjeet , Powrie Jake , Thomas Stephen , Brackenridge Anna , Breen Louise , Carroll Paul

Background: The route of oestrogen replacement has an influence on GH sensitivity in hypopituitary women, although the practical relevance of this effect remains unclear.Objectives: To compare the effects of oral and transdermal oestrogen replacement on GH requirement in adult females with hypopituitarism receiving GH replacement.Methods: This cross-sectional, observational study included 69 GH-deficient women each receiving a stab...

ea0021p404 | Thyroid | SFEBES2009

Sunitinib induced hypothyroidism: a retrospective analysis

Muralidhara Koteshwara , Joseph Debra , Guzder Rustom , Rudman Sarah , McGowan Barbara , Chowdhury Simon , Carroll Paul , Powrie Jake

Sunitinib, a tyrosine kinase inhibitor, inhibits VEGF-mediated tumour angiogenesis. Following NICE approval, it is increasingly used in the treatment of metastatic renal cell carcinoma.Hypothyroidism in sunitinib-treated individuals was first described in 2005. The aetiology remains uncertain and possibly reflects a destructive thyroiditis. Incidence rates of hypothyroidism from case series vary between 36 and 85%. We report a retrospective analysis of t...

ea0015p393 | Thyroid | SFEBES2008

Severe sight-threatening thyroid eye disease presenting de novo in an euthyroid pregnant woman

Germain Sarah , Saha Shouvik , Nelson-Piercy Cathy , Stanford Miles , Carroll Paul

Introduction: Graves’ disease is a common cause of hyperthyroidism in pregnant woman, but usually improves during pregnancy.Case: A 23-year-old Pakistani woman in her first pregnancy had no personal or family history of thyroid disease. At 30 weeks gestation she developed a swollen, red left eye, which progressed to involve the right eye. Orbital MRI demonstrated left-sided proptosis, bulky superior and inferior rectus muscles, but no extra-orbital ...

ea0013p210 | AMEND Young Investigator's Award | SFEBES2007

Routine preoperative venous sampling is not necessary in aldosterone producing adenoma (Conn’s syndrome)

Srikugan Lanitha , Thomas Stephen M , Powrie Jake K , Howard Jonathan , Brackenridge Anna , Carroll Paul V

Controversy exists as to the role of adrenal venous sampling in the assessment of primary aldosteronism (PA). There is no consensus as to how best to define successful outcome post resection of aldosterone producing adenoma (APA). We performed a retrospective analysis of the outcome of patients following unilateral adrenalectomy without pre-operative venous sampling. The study included 14 patients (9 males; mean age 47 yrs (r: 38–59 yrs) with PA and CT identified u...

ea0013p290 | Steroids | SFEBES2007

Glucocorticoid treatment and the consequences in adults with congenital adrenal hyperplasia

Doherty Emma , Powrie Jake , Breen Louise , Thomas Stephen , Brackenridge Anna , Carroll Paul

No guidelines exist for the management of Congenital Adrenal Hyperplasia (CAH) in adults. With no ideal glucocorticoid regimen to replicate normal physiology, best practice remains unclear. Concerns have been raised regarding overtreatment, particularly with longer acting steroids, and potential adverse effects on body composition and bone mineral density (BMD).We examined the case records of all 35 patients currently under review in our unit. Mean±...

ea0056p139 | Endocrine tumours and neoplasia | ECE2018

Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening

Kumar Rakshit , Joshi Mamta , Velusamy Anand , Mcgowan Barbara , Powrie Jake , Izatt Louise , Carroll Paul

Mutations in the RET gene are responsible for Multiple Endocrine Neoplasia type 2A (MEN2A), characterised by Medullary Thyroid Carcinoma (MTC) and Pheochromocytoma (PCC). It is well recognised that there is a genotype-phenotype correlation regarding likelihood of endocrine tumour development. The American Thyroid Association (ATA) has published predictive grading to guide clinical management of patients with RET mutations.Aim: In this study, we aim to as...

ea0073aep388 | Endocrine-Related Cancer | ECE2021

Clinical, genetic & imaging characteristics of mediastinal paraganglioma – a case series

Quinn Mark , Paul Carroll , McGowan Barbara , Joshi Mamta , Izatt Louise , Velusamy Anand

IntroductionParagangliomas (PGLs) are neuroendocrine tumours that arise from neural crest-derived chromaffin cells. They can develop anywhere these cells exist from the base of the skull to the pelvis. All PGLs have neuro-secretory potential and can produce symptoms due to catecholamine excess. While the majority are benign they do have malignant potential. Mediastinal PGLs are rare and often have a strong genetic predisposition. A higher proportion of t...

ea0099ep303 | Endocrine-Related Cancer | ECE2024

Penetrance and clinical phenotype of SDHA related phaeochromocytomas and paragangliomas: A single centre experience

Quinn Mark , Carroll Paul , Velusamy Anand , Oakey Rebecca , Obholzer Rupert , Izatt Louise

Background: Phaeochromocytomas and paragangliomas (PPGLs) are histologically identical tumours that exhibit significant clinical heterogeneity. At least 40% of PPGLs arise due to the presence of a pathogenic germline variant (PGV) in a known susceptibility gene. PGVs affecting the mitochondrial enzyme succinate dehydrogenase (SDHA, SDHB, SDHC and SDHD) are the most common. Phenotypic features of PPGLs secondary to SDHB and SDHD PGVs are well...